Forecast: Domestic General Government Health Expenditure in Nigeria

The analysis of Nigeria's Domestic General Government Health Expenditure as a percentage of GDP from 2024 to 2028 highlights a consistent but slight decline. With the expenditure starting at 0.48% of GDP in 2024, it is projected to gradually decrease to 0.46% by 2028. Compared to 2023, the figure for 2024 signifies continuity if 2023 values are used as a constant.

The year-on-year percentage variations are minimal for each projected year, reflecting a stability in the expenditure as part of GDP. Over the last two years of projected data, there's a noticeable reduction, albeit small, and the five-year Compound Annual Growth Rate (CAGR) is negative, indicating a very slight annual decline in government health expenditure as a percentage of GDP.

Future trends to watch for:

  • Implementation of new health policies that could alter government spending.
  • Macro-economic changes that may impact GDP and, consequently, the % of it spent on health.
  • Potential international aid or investment in Nigeria's health sector which may change the expenditure dynamics.
  • Socio-political factors that may affect budget priorities and allocations to health expenditure.

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease